Saleem Saiyad, MD
Interventional Cardiology · Tampa, FLNPI 1104824861
Payments from drug & device makers
Across 136 payments — averaging $789.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$102K
- Medtronic$1K
- Philips North America LLC$1K
- Boston Scientific$807
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$428
- Organogenesis Inc.$204
- plus $1K from 22 others
What the payments were for
- Travel & lodging$1,7222%
- Food & beverage$3,7674%
- Other$101,93695%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 6 | $102,126 |
| Medtronic(2 entities) | 16 | $1,453 |
| Philips North America LLC | 9 | $1,273 |
| Boston Scientific | 12 | $807 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 37 | $428 |
| Organogenesis Inc. | 6 | $204 |
| Cardinal Health 200 LLC | 13 | $188 |
| Covidien LP | 1 | $131 |
| Pfizer | 6 | $128 |
| GSK | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 5 | $102 |
| Cardiovascular Systems Inc. | 4 | $70 |
| Boehringer Ingelheim | 3 | $67 |
| Novo Nordisk | 3 | $62 |
| Surmodics, Inc. | 1 | $29 |
| Eagle Pharmaceuticals, Inc. | 1 | $25 |
| Abbott | 1 | $23 |
| Amgen | 1 | $20 |
| Chiesi USA, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Triad Life Sciences Inc. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $18 |
| Avinger Inc. | 1 | $17 |
| Biocompatibles, Inc. | 1 | $16 |
| Acacia Pharma Inc | 1 | $16 |
| Novartis | 1 | $14 |
| Penumbra, Inc. | 1 | $12 |
| 3b Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$56,287
- Auryon Atherectomy Catheter 1.5 mm OTW$45,769
- Auryon Atherectomy Catheter 0.9 mm OTW$45,769
- VenaCure EVLT$45,769
- AngioDynamics$45,769
- IGT D Peripheral$1,105
- WATCHMAN Access System$438
- ELUVIA$135
- EndoFlip$131
- ANORO$125
How this compares
$107,424 in reported general payments places this provider in the 80th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 108 | $106,628 |
| OzempicSemaglutide | 57 | $63,921 |
| MounjaroTirzepatide | 13 | $13,531 |
| XareltoRivaroxaban | 22 | $13,470 |
| MyrbetriqMirabegron | 11 | $5,206 |
| Diltiazem 12hr ErDiltiazem Hcl | 32 | $4,121 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 97 | $3,832 |
| Prasugrel Hcl | 28 | $2,751 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 81 | $2,330 |
| ClopidogrelClopidogrel Bisulfate | 266 | $2,026 |
| Levothyroxine Sodium | 38 | $1,693 |
| Niacin ErNiacin | 12 | $1,559 |
| Clonidine | 15 | $1,328 |
| Atorvastatin Calcium | 214 | $1,209 |
| Midodrine Hcl | 23 | $1,191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $128 | $106,628108 claims |
| Novo NordiskOzempic | $62 | $63,92157 claims |
| Johnson & JohnsonXarelto | $19 | $13,47022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 623 interventional cardiology providers in Florida.
Other interventional cardiology in Tampa
- Saihari SadanandanTampa$558K
- Fadi MatarTampa$448K
- Bibhu MohantyTampa$304K
- Dominick AngiolilloJacksonville$4M
- Douglas SpriggsClearwater$3.2M
- Rakesh PrashadOcala$3.1M
- Aldo Martinez FleitesMiami Lakes$2.2M
- Rohit AminPensacola$2M
- Roberto CubedduNaples$2M
- Arthur LeeGainesville$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.